Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple.
Schütz NP, Ochoa P, Duarte P, Remaggi G, Yantorno S, Corzo A, Zabaljauregui S, Shanley C, Lopresti S, Orlando S, Verri V, Quiroga L, García CA, Fernández V, Fantl D. Schütz NP, et al. Among authors: yantorno s. Hematol Oncol. 2020 Aug;38(3):363-371. doi: 10.1002/hon.2729. Epub 2020 Apr 20. Hematol Oncol. 2020. PMID: 32196120
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple.
Duarte PJ, Schutz NP, Ochoa P, Yantorno S, Orlando S, Lopresti S, Zabaljauregui S, Aizpurua F, Shanley C, Giannini E, Garate G, Foncuberta C, Milone J, Riveros D, Fantl D. Duarte PJ, et al. Among authors: yantorno s. Expert Rev Hematol. 2021 Mar;14(3):315-322. doi: 10.1080/17474086.2021.1886073. Epub 2021 Mar 1. Expert Rev Hematol. 2021. PMID: 33541156
Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.
Peña C, Riva E, Schutz N, Tarín-Arzaga L, Martínez-Cordero H, Bove V, Osorio R, Chandía M, Beltrán C, Schulz J, Cardemil D, Contreras C, Vergara CG, Donoso J, Espinoza M, La Rocca G, López-Vidal H, León P, Rojas Hopkins C, Soto P, Aranda S, Torres V, Roa M, Ochoa P, Duarte PJ, Remaggi G, Yantorno S, Corzo A, Zabaljauregui S, Shanley C, Lopresti S, Orlando S, Verri V, Quiroga L, García C, Fernández V, Ramirez J, Molina A, Pacheco M, Mite A, Reyes I, Sabando B, Ramírez F, Sossa C, Abello V, Idrobo H, Galvez Cardenas KM, Saavedra D, Quintero G, Gazitúa R, Gaviria L, Gomez R, Osuna M, Henao-Uribe A, Cantú-Martínez O, Gómez-Almaguer D, García-Navarrete YI, Cruz-Mora A, Cantero-Fortiz Y, Ruiz-Argüelles GJ, Fantl D. Peña C, et al. Among authors: yantorno s. Leuk Lymphoma. 2020 Dec;61(13):3112-3119. doi: 10.1080/10428194.2020.1804558. Epub 2020 Aug 26. Leuk Lymphoma. 2020. PMID: 32844699
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
Riva E, Duarte PJ, Valcárcel B, Remaggi G, Murrieta I, Corzo A, Del Carpio D, Peña C, Vásquez J, Bove V, Teixeira L, Fleury-Perini G, Yantorno S, Samánez C, Lopresti S, Altamirano M, Villela L, Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Montaño E, Verri V, Zamora Pérez E, Pérez Jacobo F, Idrobo H, Martínez-Cordero H, Beltran BE, Ramírez J, Castillo JJ, Malpica Castillo LE. Riva E, et al. Among authors: yantorno s. JCO Glob Oncol. 2022 Aug;8:e2100380. doi: 10.1200/GO.21.00380. JCO Glob Oncol. 2022. PMID: 35939775 Free PMC article.
Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score.
Berro M, Chhabra S, Piñana JL, Arbelbide J, Rivas MM, Basquiera AL, Vitriu A, Requejo A, Milovic V, Yantorno S, Bentolila G, Garcia JJ, Castro M, Palmer S, Saslavsky M, Duarte P, Cerutti A, Jarchum G, Tisi Baña M, Thapa B, Solano C, Sureda A, Rovira M, Shaw BE, Kusminsky G; Grupo Argentino de Trasplante de Médula Ósea y Terapia Celular (GATMO-TC). Berro M, et al. Among authors: yantorno s. Biol Blood Marrow Transplant. 2020 Oct;26(10):1828-1832. doi: 10.1016/j.bbmt.2020.06.028. Epub 2020 Jul 5. Biol Blood Marrow Transplant. 2020. PMID: 32640312 Free article.
Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors.
Basquiera AL, Berro M, Yantorno S, Castro M, Requejo A, Sorrentino M, Sutovsky D, Giunta D, Palmer S, Vitriu A, Ferini G, Bendek G, Szelagowski M, Rapán ML, Escobar NF, Duarte P, Cerutti A, Cattaneo M, Martinez-Rolón J, Jaimovich G, Bordone J, Milovic V, Kusminsky G, Arbelbide JA; Grupo Argentino de Trasplante de Médula Ósea (GATMO). Basquiera AL, et al. Among authors: yantorno s. Bone Marrow Transplant. 2020 Feb;55(2):400-408. doi: 10.1038/s41409-019-0687-x. Epub 2019 Sep 24. Bone Marrow Transplant. 2020. PMID: 31551518
The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.
Gómez-Almaguer D, Vázquez-Mellado A, Navarro-Cabrera JR, Abello-Polo V, Milovic V, García J, Basquiera AL, Saba S, Balladares G, Vela-Ojeda J, Gómez S, Karduss-Aurueta A, Bustinza-Álvarez A, Requejo A, Feldman L, Jaime-Pérez JC, Yantorno S, Kusminsky G, Gutiérrez-Aguirre CH, Arbelbide J, Martinez-Rolon J, Jarchum G, Jaimovich G, Riera L, Pedraza-Mesa E, Villamizar-Gómez L, Herrera-Rojas MÁ, Gamboa-Alonso MM, Foncuberta C, Rodríguez-González G, García Ruiz-Esparza MA, Hernández-Maldonado E, Paz-Infanzón M, González-López E, Ruiz-Argüelles GJ. Gómez-Almaguer D, et al. Among authors: yantorno s. Bone Marrow Transplant. 2017 Jan;52(1):41-46. doi: 10.1038/bmt.2016.212. Epub 2016 Aug 22. Bone Marrow Transplant. 2017. PMID: 27548465 Clinical Trial.
Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro M, Arbelbide JA, Rivas MM, Basquiera AL, Ferini G, Vitriu A, Foncuberta C, Fernandez Escobar N, Requejo A, Milovic V, Yantorno S, Szelagoswki M, Martinez Rolon J, Bentolila G, Garcia JJ, Garcia P, Caeiro G, Castro M, Jaimovich G, Palmer S, Trucco JI, Bet LA, Shaw BE, Kusminsky GD. Berro M, et al. Among authors: yantorno s. Biol Blood Marrow Transplant. 2017 Oct;23(10):1646-1650. doi: 10.1016/j.bbmt.2017.06.014. Epub 2017 Jun 29. Biol Blood Marrow Transplant. 2017. PMID: 28669923 Free article.
Comparison of matched sibling, unrelated and haploidentical donors in hematopoietic stem cell transplantation. A real-world experience from the Argentine Group for Bone Marrow Transplantation and Cell Therapy (GATMO-TC).
Trucco JI, Berro M, Basquiera AL, García P, Yantorno S, Palmer S, Requejo A, Vitriú A, Bentolila G, Rivas MM, Ferini G, García JJ, Milone J, Stemmelin G, Jaimovich G, Foncuberta C, Martínez Rolón J, Kusminsky GD; GATMO-TC (Grupo Argentino de Trasplante de Médula ósea y Terapia Celular). Trucco JI, et al. Among authors: yantorno s. Medicina (B Aires). 2020;80(6):654-662. Medicina (B Aires). 2020. PMID: 33254110 Free article. English.
Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
Rivas MM, Berro M, Prates MV, Yantorno S, Fiad L, Arbelbide JA, Basquiera AL, Ferini GA, García JJ, García PA, Riera L, Jarchum G, Baso A, Real J, Castro M, Jaimovich G, Martinez Rolón J, Foncuberta C, Saba S, Kusminsky G; GATMO (Grupo Argentino de Trasplante de Médula Ósea). Rivas MM, et al. Among authors: yantorno s. Bone Marrow Transplant. 2020 Jan;55(1):117-125. doi: 10.1038/s41409-019-0640-z. Epub 2019 Aug 21. Bone Marrow Transplant. 2020. PMID: 31435033
29 results